Clec9A-DTR delayed DT group allows us to assess whether CD103+ cDC1s are required to maintain the memory effector CD8+ T cell pool, we omitted DT injections during the first 3 weeks of infection to allow effective primary effector antiviral CD8+ T cell response. This evidence concerns the gene CD8A and infection.